TY  - RPRT
TI  - Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies
AU  - Woo, H. G.
AU  - Shah, M.
PY  - 2021
DO  - 10.1101/2021.12.04.471200
UR  - https://www.biorxiv.org/content/10.1101/2021.12.04.471200v1
ID  - 10.1101/2021.12.04.471200
ER  -